ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals Inc (PHAT)

5.67
0.13
(2.35%)
Closed February 23 3:00PM
5.77
0.10
(1.76%)
After Hours: 5:56PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

PHAT News

Official News Only

PHAT Discussion

View Posts
rolvram rolvram 3 months ago
Blackrock keeps accumulating
https://stockzoa.com/ticker/phat/ownership/blackrock/#google_vignette
👍️0
Monksdream Monksdream 5 months ago
PHAT new 52=high

👍️0
MiamiGent MiamiGent 7 months ago
PHAT Nice! Account increased 11%! Was stacked.
👍️0
MiamiGent MiamiGent 7 months ago
PHAT 28.5% Revenue beat!
👍️0
MiamiGent MiamiGent 7 months ago
PHAT Still in.
👍️0
FALCON1 FALCON1 7 months ago
https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation
👍️0
MiamiGent MiamiGent 7 months ago
HC Wainwright & Co. Reiterates Buy on Phathom Pharmaceuticals, Maintains $28 Price Target
BENZINGA

Jul-19-2024 6:41 a.m. ET

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (PHAT) with a Buy and maintains $28 price target.
👍️0
MiamiGent MiamiGent 7 months ago
PHAT I'm hanging in!
👍️0
MiamiGent MiamiGent 7 months ago
BRIEF-Phathom Pharmaceuticals Announces FDA Approval Of Voquezna® (Vonoprazan) Tablets For The Relief Of Heartburn Associated With Non-Erosive Gerd In Adults
REUTERS

Jul-18-2024 8:41 a.m. ET

July 18 (Reuters) - Phathom Pharmaceuticals Inc (PHAT) :

* PHATHOM PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF VOQUEZNA® (VONOPRAZAN) TABLETS FOR THE RELIEF OF HEARTBURN ASSOCIATED WITH NON-EROSIVE GERD IN ADULTS

* PHATHOM PHARMACEUTICALS INC (PHAT): VOQUEZNA MET ITS PRIMARY ENDPOINT IN ITS PHASE 3 PIVOTAL TRIAL Source text for Eikon: Further company coverage:
👍️0
MiamiGent MiamiGent 7 months ago
$PHAT FLE.
👍️0
MiamiGent MiamiGent 7 months ago
PHAT In @ 12.60's
👍️0
Monksdream Monksdream 10 months ago
PHAT under $10
👍️0
Monksdream Monksdream 12 months ago
PHAT 10Q due March 7
👍️0

Your Recent History

Delayed Upgrade Clock